Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Survivin: a promising tumor biomarker.

Duffy MJ, O'Donovan N, Brennan DJ, Gallagher WM, Ryan BM.

Cancer Lett. 2007 Apr 28;249(1):49-60. Epub 2007 Feb 1. Review.

PMID:
17275177
2.

Survivin: role in diagnosis, prognosis, and treatment of bladder cancer.

Akhtar M, Gallagher L, Rohan S.

Adv Anat Pathol. 2006 May;13(3):122-6. Review.

PMID:
16778475
3.

Survivin: an inhibitor of apoptosis in pediatric cancer.

Fangusaro JR, Caldas H, Jiang Y, Altura RA.

Pediatr Blood Cancer. 2006 Jul;47(1):4-13. Review.

PMID:
16534789
4.

Targeting survivin in cancer therapy: fulfilled promises and open questions.

Pennati M, Folini M, Zaffaroni N.

Carcinogenesis. 2007 Jun;28(6):1133-9. Epub 2007 Mar 6. Review.

PMID:
17341657
5.

Survivin - an anti-apoptosis protein: its biological roles and implications for cancer and beyond.

Chiou SK, Jones MK, Tarnawski AS.

Med Sci Monit. 2003 Apr;9(4):PI25-9. Review.

PMID:
12709681
6.

Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small-cell lung cancer.

Bria E, Visca P, Novelli F, Casini B, Diodoro MG, Perrone-Donnorso R, Botti C, Sperduti I, Facciolo F, Milella M, Cecere FL, Cognetti F, Mottolese M.

Eur J Surg Oncol. 2008 May;34(5):593-8. Epub 2007 Aug 10.

PMID:
17693049
7.

Survivin, a cancer target with an emerging role in normal adult tissues.

Fukuda S, Pelus LM.

Mol Cancer Ther. 2006 May;5(5):1087-98. Review.

8.

Bladder cancer diagnosis and recurrence prognosis: comparison of markers with emphasis on survivin.

Schultz IJ, Witjes JA, Swinkels DW, de Kok JB.

Clin Chim Acta. 2006 Jun;368(1-2):20-32. Epub 2006 Feb 9. Review.

PMID:
16480698
9.

Survivin: a new target for anti-cancer therapy.

Ryan BM, O'Donovan N, Duffy MJ.

Cancer Treat Rev. 2009 Nov;35(7):553-62. doi: 10.1016/j.ctrv.2009.05.003. Epub 2009 Jun 25. Review.

PMID:
19559538
10.

Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker.

Nouraee N, Mowla SJ, Ozhand A, Parvin M, Ziaee SA, Hatefi N.

Urol J. 2009 Spring;6(2):101-8.

PMID:
19472128
11.

Cancer cells survive with survivin.

Yamamoto H, Ngan CY, Monden M.

Cancer Sci. 2008 Sep;99(9):1709-14. doi: 10.1111/j.1349-7006.2008.00870.x. Epub 2008 Jun 5. Review.

12.

Differential expression of survivin and its splice variants, survivin-DeltaEx3 and survivin-2B, in bladder cancer.

Atlasi Y, Mowla SJ, Ziaee SA.

Cancer Detect Prev. 2009;32(4):308-13. doi: 10.1016/j.cdp.2008.12.001. Epub 2009 Jan 30.

PMID:
19186007
13.

The universal character of the tumor-associated antigen survivin.

Andersen MH, Svane IM, Becker JC, Straten PT.

Clin Cancer Res. 2007 Oct 15;13(20):5991-4. Review.

14.

Emmprin and survivin predict response and survival following cisplatin-containing chemotherapy in patients with advanced bladder cancer.

Als AB, Dyrskjøt L, von der Maase H, Koed K, Mansilla F, Toldbod HE, Jensen JL, Ulhøi BP, Sengeløv L, Jensen KM, Orntoft TF.

Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4407-14.

15.

Combinations of apoptosis and cell-cycle control biomarkers predict the outcome of human melanoma.

Piras F, Perra MT, Murtas D, Minerba L, Floris C, Maxia C, Demurtas P, Ugalde J, Ribatti D, Sirigu P.

Oncol Rep. 2008 Aug;20(2):271-7.

PMID:
18636186
16.

Survivin expression in childhood medulloblastomas: a possible diagnostic and prognostic marker.

Bodey B, Bodey V, Siegel SE, Kaiser HE.

In Vivo. 2004 Nov-Dec;18(6):713-8.

17.

Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.

Khan Z, Tiwari RP, Mulherkar R, Sah NK, Prasad GB, Shrivastava BR, Bisen PS.

Head Neck. 2009 Aug;31(8):1039-48. doi: 10.1002/hed.21071.

PMID:
19340865
18.

Expression patterns and prognostic significance of inhibitor of apoptosis proteins in adenoid cystic carcinoma and pleomorphic adenoma of lachrymal gland.

Liao Y, Zeng H, Wang X, Huang Y, Chen N, Ge B, Tang L, Luo Q.

Exp Eye Res. 2009 Jan;88(1):4-11. doi: 10.1016/j.exer.2008.09.015. Epub 2008 Oct 9.

PMID:
18955046
19.

Survivin expression is associated with bladder cancer presence, stage, progression, and mortality.

Shariat SF, Ashfaq R, Karakiewicz PI, Saeedi O, Sagalowsky AI, Lotan Y.

Cancer. 2007 Mar 15;109(6):1106-13.

Supplemental Content

Support Center